APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Live Attenuated Japanese Encephalitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Live Attenuated Japanese Encephalitis Vaccine Market Analysis and Forecast 2026-2032

Report ID 174008360222 December 2025193 pages

Choose your research edition.

Industry ResearchLive Attenuated Japanese Encephalitis Vaccine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Live Attenuated Japanese Encephalitis Vaccine Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Live Attenuated Japanese Encephalitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Live Attenuated Japanese Encephalitis Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Live Attenuated Japanese Encephalitis Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Live Attenuated Japanese Encephalitis Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Live Attenuated Japanese Encephalitis Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Live Attenuated Japanese Encephalitis Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Live Attenuated Japanese Encephalitis Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Live Attenuated Japanese Encephalitis Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Live Attenuated Japanese Encephalitis Vaccine include Wuhan Institute of Biological Products, Sanofi, Novartis, Lanzhou Institute of Biological Products, Chengdu Institute of Biological Products, Cheng Da Biology, Beijing Temple of Heaven Biological Products, Valneva and Glovax Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Live Attenuated Japanese Encephalitis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Live Attenuated Japanese Encephalitis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Live Attenuated Japanese Encephalitis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Live Attenuated Japanese Encephalitis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Live Attenuated Japanese Encephalitis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Live Attenuated Japanese Encephalitis Vaccine sales, projected growth trends, production technology, application and end-user industry.

Live Attenuated Japanese Encephalitis Vaccine Segment by Company

Wuhan Institute of Biological Products

Sanofi

Novartis

Lanzhou Institute of Biological Products

Chengdu Institute of Biological Products

Cheng Da Biology

Beijing Temple of Heaven Biological Products

Valneva

Glovax Co., Ltd.

Biocelect Pty Ltd

Bharat Biotech

Live Attenuated Japanese Encephalitis Vaccine Segment by Type

2.5ml

1ml

0.5ml

Live Attenuated Japanese Encephalitis Vaccine Segment by Application

Hospital

Clinic

Live Attenuated Japanese Encephalitis Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Attenuated Japanese Encephalitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Live Attenuated Japanese Encephalitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Attenuated Japanese Encephalitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Live Attenuated Japanese Encephalitis Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Live Attenuated Japanese Encephalitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Live Attenuated Japanese Encephalitis Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 2.5ml Major Manufacturers Table 3. 1ml Major Manufacturers Table 4. 0.5ml Major Manufacturers Table 5. Global Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Live Attenuated Japanese Encephalitis Vaccine Industry Trends Table 9. Live Attenuated Japanese Encephalitis Vaccine Industry Drivers Table 10. Live Attenuated Japanese Encephalitis Vaccine Industry Opportunities and Challenges Table 11. Live Attenuated Japanese Encephalitis Vaccine Industry Restraints Table 12. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Live Attenuated Japanese Encephalitis Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2021-2026) & (k units) Table 19. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2027-2032) & (k units) Table 20. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Live Attenuated Japanese Encephalitis Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Live Attenuated Japanese Encephalitis Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Live Attenuated Japanese Encephalitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Product Type & Application Table 30. Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Live Attenuated Japanese Encephalitis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (k units) Table 40. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2027-2032) & (k units) Table 41. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Live Attenuated Japanese Encephalitis Vaccine Price by Type (2021-2026) & (US$/unit) Table 44. Global Live Attenuated Japanese Encephalitis Vaccine Price by Type (2027-2032) & (US$/unit) Table 45. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2027-2032) & (k units) Table 53. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Live Attenuated Japanese Encephalitis Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Live Attenuated Japanese Encephalitis Vaccine Price by Application (2027-2032) & (US$/unit) Table 57. Wuhan Institute of Biological Products Company Information Table 58. Wuhan Institute of Biological Products Business Overview Table 59. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 61. Wuhan Institute of Biological Products Recent Development Table 62. Sanofi Company Information Table 63. Sanofi Business Overview Table 64. Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Sanofi Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 66. Sanofi Recent Development Table 67. Novartis Company Information Table 68. Novartis Business Overview Table 69. Novartis Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Novartis Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 71. Novartis Recent Development Table 72. Lanzhou Institute of Biological Products Company Information Table 73. Lanzhou Institute of Biological Products Business Overview Table 74. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 76. Lanzhou Institute of Biological Products Recent Development Table 77. Chengdu Institute of Biological Products Company Information Table 78. Chengdu Institute of Biological Products Business Overview Table 79. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 81. Chengdu Institute of Biological Products Recent Development Table 82. Cheng Da Biology Company Information Table 83. Cheng Da Biology Business Overview Table 84. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 86. Cheng Da Biology Recent Development Table 87. Beijing Temple of Heaven Biological Products Company Information Table 88. Beijing Temple of Heaven Biological Products Business Overview Table 89. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 91. Beijing Temple of Heaven Biological Products Recent Development Table 92. Valneva Company Information Table 93. Valneva Business Overview Table 94. Valneva Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Valneva Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 96. Valneva Recent Development Table 97. Glovax Co., Ltd. Company Information Table 98. Glovax Co., Ltd. Business Overview Table 99. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 101. Glovax Co., Ltd. Recent Development Table 102. Biocelect Pty Ltd Company Information Table 103. Biocelect Pty Ltd Business Overview Table 104. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 106. Biocelect Pty Ltd Recent Development Table 107. Bharat Biotech Company Information Table 108. Bharat Biotech Business Overview Table 109. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 111. Bharat Biotech Recent Development Table 112. North America Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (k units) Table 115. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2027-2032) & (k units) Table 116. North America Live Attenuated Japanese Encephalitis Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 117. North America Live Attenuated Japanese Encephalitis Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 118. North America Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (k units) Table 121. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2027-2032) & (k units) Table 122. North America Live Attenuated Japanese Encephalitis Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 123. North America Live Attenuated Japanese Encephalitis Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 124. North America Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 128. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026) & (k units) Table 129. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2027-2032) & (k units) Table 130. North America Live Attenuated Japanese Encephalitis Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 131. North America Live Attenuated Japanese Encephalitis Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 132. United States Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 133. Canada Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 134. Mexico Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 135. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (k units) Table 138. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2027-2032) & (k units) Table 139. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 140. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 141. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (k units) Table 144. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2027-2032) & (k units) Table 145. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 146. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 147. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 151. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026) & (k units) Table 152. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2027-2032) & (k units) Table 153. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 154. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 155. Germany Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 156. France Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 157. U.K. Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 158. Italy Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 159. Russia Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 160. Spain Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 161. Netherlands Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 162. Switzerland Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 163. Sweden Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 164. Poland Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 165. China Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 166. China Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 167. China Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (k units) Table 168. China Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2027-2032) & (k units) Table 169. China Live Attenuated Japanese Encephalitis Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 170. China Live Attenuated Japanese Encephalitis Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 171. China Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 172. China Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 173. China Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (k units) Table 174. China Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2027-2032) & (k units) Table 175. China Live Attenuated Japanese Encephalitis Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 176. China Live Attenuated Japanese Encephalitis Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 177. Asia Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 178. Asia Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 179. Asia Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (k units) Table 180. Asia Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2027-2032) & (k units) Table 181. Asia Live Attenuated Japanese Encephalitis Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 182. Asia Live Attenuated Japanese Encephalitis Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 183. Asia Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (k units) Table 186. Asia Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2027-2032) & (k units) Table 187. Asia Live Attenuated Japanese Encephalitis Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 188. Asia Live Attenuated Japanese Encephalitis Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 189. Asia Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Asia Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Asia Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 193. Asia Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026) & (k units) Table 194. Asia Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2027-2032) & (k units) Table 195. Asia Live Attenuated Japanese Encephalitis Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 196. Asia Live Attenuated Japanese Encephalitis Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 197. Japan Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 198. South Korea Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 199. India Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 200. Australia Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 201. Taiwan Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 202. Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 203. SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (k units) Table 206. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2027-2032) & (k units) Table 207. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 208. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 209. SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 210. SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 211. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (k units) Table 212. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2027-2032) & (k units) Table 213. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 214. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 215. SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 219. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026) & (k units) Table 220. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2027-2032) & (k units) Table 221. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 222. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 223. Brazil Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 224. Argentina Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 225. Chile Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 226. Colombia Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 227. Peru Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 228. Saudi Arabia Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 229. Israel Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 230. UAE Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 231. Turkey Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 232. Iran Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 233. Egypt Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Live Attenuated Japanese Encephalitis Vaccine Distributors List Table 237. Live Attenuated Japanese Encephalitis Vaccine Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Live Attenuated Japanese Encephalitis Vaccine Image Figure 2. Global Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Live Attenuated Japanese Encephalitis Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. 2.5ml Image Figure 5. 1ml Image Figure 6. 0.5ml Image Figure 7. Global Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Live Attenuated Japanese Encephalitis Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Global Live Attenuated Japanese Encephalitis Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Live Attenuated Japanese Encephalitis Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Live Attenuated Japanese Encephalitis Vaccine Sales (2021-2032) & (k units) Figure 17. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Live Attenuated Japanese Encephalitis Vaccine Sales YoY (2021-2032) & (k units) Figure 20. Europe Live Attenuated Japanese Encephalitis Vaccine Sales YoY (2021-2032) & (k units) Figure 21. China Live Attenuated Japanese Encephalitis Vaccine Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Live Attenuated Japanese Encephalitis Vaccine Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales YoY (2021-2032) & (k units) Figure 24. Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Live Attenuated Japanese Encephalitis Vaccine Sales Share by Type (2021-2032) Figure 41. North America Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Live Attenuated Japanese Encephalitis Vaccine Sales Share by Application (2021-2032) Figure 43. North America Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Live Attenuated Japanese Encephalitis Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Share by Country (2021-2032) Figure 51. China Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Type (2021-2032) Figure 52. China Live Attenuated Japanese Encephalitis Vaccine Sales Share by Type (2021-2032) Figure 53. China Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Application (2021-2032) Figure 54. China Live Attenuated Japanese Encephalitis Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Live Attenuated Japanese Encephalitis Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Live Attenuated Japanese Encephalitis Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Live Attenuated Japanese Encephalitis Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales Share by Country (2021-2032) Figure 67. Live Attenuated Japanese Encephalitis Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Live Attenuated Japanese Encephalitis Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5ml
  • 1ml
  • 0.5ml
Applications
  • Hospital
  • Clinic
Companies covered
  • Wuhan Institute of Biological Products
  • Sanofi
  • Novartis
  • Lanzhou Institute of Biological Products
  • Chengdu Institute of Biological Products
  • Cheng Da Biology
  • Beijing Temple of Heaven Biological Products
  • Valneva
  • Glovax Co., Ltd.
  • Biocelect Pty Ltd
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Live Attenuated Japanese Encephalitis Vaccine Market by Type
  3. 1.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 2.5ml
  5. 1.2.3 1ml
  6. 1.2.4 0.5ml
  7. 1.3 Live Attenuated Japanese Encephalitis Vaccine Market by Application
  8. 1.3.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Live Attenuated Japanese Encephalitis Vaccine Market Dynamics
  1. 2.1 Live Attenuated Japanese Encephalitis Vaccine Industry Trends
  2. 2.2 Live Attenuated Japanese Encephalitis Vaccine Industry Drivers
  3. 2.3 Live Attenuated Japanese Encephalitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Live Attenuated Japanese Encephalitis Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Region
  3. 3.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Live Attenuated Japanese Encephalitis Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region
  9. 3.4.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Manufacturers
  6. 4.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Live Attenuated Japanese Encephalitis Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Live Attenuated Japanese Encephalitis Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Live Attenuated Japanese Encephalitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Live Attenuated Japanese Encephalitis Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Live Attenuated Japanese Encephalitis Vaccine Tier 1, Tier 2, and Tier 3
5 Live Attenuated Japanese Encephalitis Vaccine Market by Type
  1. 5.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Type
  2. 5.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type
  6. 5.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Live Attenuated Japanese Encephalitis Vaccine Price by Type
6 Live Attenuated Japanese Encephalitis Vaccine Market by Application
  1. 6.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Application
  2. 6.1.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application
  6. 6.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Live Attenuated Japanese Encephalitis Vaccine Price by Application
7 Company Profiles
  1. 7.1 Wuhan Institute of Biological Products
  2. 7.1.1 Wuhan Institute of Biological Products Company Information
  3. 7.1.2 Wuhan Institute of Biological Products Business Overview
  4. 7.1.3 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  6. 7.1.5 Wuhan Institute of Biological Products Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Lanzhou Institute of Biological Products
  20. 7.4.1 Lanzhou Institute of Biological Products Company Information
  21. 7.4.2 Lanzhou Institute of Biological Products Business Overview
  22. 7.4.3 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  24. 7.4.5 Lanzhou Institute of Biological Products Recent Developments
  25. 7.5 Chengdu Institute of Biological Products
  26. 7.5.1 Chengdu Institute of Biological Products Company Information
  27. 7.5.2 Chengdu Institute of Biological Products Business Overview
  28. 7.5.3 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  30. 7.5.5 Chengdu Institute of Biological Products Recent Developments
  31. 7.6 Cheng Da Biology
  32. 7.6.1 Cheng Da Biology Company Information
  33. 7.6.2 Cheng Da Biology Business Overview
  34. 7.6.3 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  36. 7.6.5 Cheng Da Biology Recent Developments
  37. 7.7 Beijing Temple of Heaven Biological Products
  38. 7.7.1 Beijing Temple of Heaven Biological Products Company Information
  39. 7.7.2 Beijing Temple of Heaven Biological Products Business Overview
  40. 7.7.3 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  42. 7.7.5 Beijing Temple of Heaven Biological Products Recent Developments
  43. 7.8 Valneva
  44. 7.8.1 Valneva Company Information
  45. 7.8.2 Valneva Business Overview
  46. 7.8.3 Valneva Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Valneva Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  48. 7.8.5 Valneva Recent Developments
  49. 7.9 Glovax Co., Ltd.
  50. 7.9.1 Glovax Co., Ltd. Company Information
  51. 7.9.2 Glovax Co., Ltd. Business Overview
  52. 7.9.3 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  54. 7.9.5 Glovax Co., Ltd. Recent Developments
  55. 7.10 Biocelect Pty Ltd
  56. 7.10.1 Biocelect Pty Ltd Company Information
  57. 7.10.2 Biocelect Pty Ltd Business Overview
  58. 7.10.3 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  60. 7.10.5 Biocelect Pty Ltd Recent Developments
  61. 7.11 Bharat Biotech
  62. 7.11.1 Bharat Biotech Company Information
  63. 7.11.2 Bharat Biotech Business Overview
  64. 7.11.3 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  66. 7.11.5 Bharat Biotech Recent Developments
8 North America
  1. 8.1 North America Live Attenuated Japanese Encephalitis Vaccine Market Size by Type
  2. 8.1.1 North America Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Live Attenuated Japanese Encephalitis Vaccine Price by Type (2021-2032)
  5. 8.2 North America Live Attenuated Japanese Encephalitis Vaccine Market Size by Application
  6. 8.2.1 North America Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Live Attenuated Japanese Encephalitis Vaccine Price by Application (2021-2032)
  9. 8.3 North America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
  10. 8.3.1 North America Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Live Attenuated Japanese Encephalitis Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size by Type
  2. 9.1.1 Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Live Attenuated Japanese Encephalitis Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size by Application
  6. 9.2.1 Europe Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Live Attenuated Japanese Encephalitis Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
  10. 9.3.1 Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Live Attenuated Japanese Encephalitis Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Live Attenuated Japanese Encephalitis Vaccine Market Size by Type
  2. 10.1.1 China Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Live Attenuated Japanese Encephalitis Vaccine Price by Type (2021-2032)
  5. 10.2 China Live Attenuated Japanese Encephalitis Vaccine Market Size by Application
  6. 10.2.1 China Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Live Attenuated Japanese Encephalitis Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Live Attenuated Japanese Encephalitis Vaccine Market Size by Type
  2. 11.1.1 Asia Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Live Attenuated Japanese Encephalitis Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Live Attenuated Japanese Encephalitis Vaccine Market Size by Application
  6. 11.2.1 Asia Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Live Attenuated Japanese Encephalitis Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
  10. 11.3.1 Asia Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Live Attenuated Japanese Encephalitis Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Live Attenuated Japanese Encephalitis Vaccine Market Size by Type
  2. 12.1.1 SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Live Attenuated Japanese Encephalitis Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Live Attenuated Japanese Encephalitis Vaccine Market Size by Application
  6. 12.2.1 SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Live Attenuated Japanese Encephalitis Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
  10. 12.3.1 SAMEA Live Attenuated Japanese Encephalitis Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Live Attenuated Japanese Encephalitis Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Live Attenuated Japanese Encephalitis Vaccine Value Chain Analysis
  2. 13.1.1 Live Attenuated Japanese Encephalitis Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Live Attenuated Japanese Encephalitis Vaccine Production Mode & Process
  6. 13.2 Live Attenuated Japanese Encephalitis Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Live Attenuated Japanese Encephalitis Vaccine Distributors
  9. 13.2.3 Live Attenuated Japanese Encephalitis Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst